The Europe Medical Aesthetics Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030).
In cosmetic medicine, minimally invasive and non-surgical aesthetic treatments are rising, providing a convenient and lower-risk alternative to conventional surgery. These procedures target different aesthetic concerns, including Botox, dermal fillers, laser therapy, chemical peels, and microdermabrasion. Their appeal lies in their minimal inactivity, making them suitable for a speedy recovery and simple return to daily activities. Due to their accessibility and customizability, they are acquiring popularity across all age groups. Importantly, these treatments minimize scarring, making them the treatment of choice for those concerned with surgical scars.
The market in emerging economies presents substantial opportunities due to several factors. As the middle class grows and discretionary income rises, more individuals invest in cosmetic treatments. These nations may also attract medical travellers seeking affordable, high-quality procedures. The relatively untapped markets in these regions provide opportunities for new entrants while technological advances improve the quality of treatment.
Many patients in Germany prefer non-invasive and minimally invasive procedures due to their efficiency, shorter recovery times, and lower risk profiles compared to traditional surgical interventions. To ensure safe and effective outcomes, individuals considering these treatments should consult with qualified healthcare providers with expertise in aesthetic medicine. Additionally, adherence to proper aftercare and maintenance is essential for long-lasting results. Due to the above-mentioned factors the market will grow significantly in this region.
The Germany market dominated the Europe Medical Aesthetics Market by Country in 2022; and would continue to be a dominant market till 2030, thereby, achieving a market value of $1,995.7 million by 2030. The UK market is exhibiting a CAGR of 9.1% during (2023 - 2030). Additionally, The France market would experience a CAGR of 10.8% during (2023 - 2030).
Based on End User, the market is segmented into Clinics, Hospitals, & Medicals Spas, Beauty Centres, & Home Care Settings. Based on Procedure, the market is segmented into Non-Surgical Procedures (Anti-Aging And Skin Rejuvenation, Tattoo & Scar Removal, Hair Removal, Lipolysis, Others), & Surgical Procedures (Breast Augmentation, Facelift & Body Lift, Rhinoplasty, Others). Based on Product, the market is segmented into Facial Aesthetic Products, Body Contouring Devices, Hair Removal Devices, Physician-dispensed cosmeceuticals And Skin Lighteners, Cosmetics Implant, Skin Aesthetic Devices, Tattoo Removal Devices, & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Medical Aesthetics Market will Hit $31.1 Billion by 2030, at a CAGR of 10.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC (AbbVie, Inc.), Alma Lasers Ltd. (Sisram Medical Ltd.), Bausch Health Companies Inc, Anika Therapeutics, Inc, Johnson & Johnson, Merz Pharma GmbH & Co. KGaA, Candela corporation, Lumenis Be Ltd., Galderma S.A., and Cutera, Inc.
By End User
By Procedure
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 